<ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>
    歡迎來到上海通蔚!

    021-54845833/15800441009

    品質保證 · 通蔚試劑

    當前位置: 首頁 > 科研產品 > 科研抗體 > 一抗 > 兔抗LRRC15多克隆抗體

    產品中心

    • 兔抗LRRC15多克隆抗體

      規(guī)格:
      價格:
      • 品牌 : 通蔚生物
      • 目錄號 : TW11515
      • 應用 : 僅供科研使用
      • 貨期 : 現貨
      • 規(guī)格 :100ul/200ul/25ul
    • 商品詳情
    • 參考文獻
    • 說明書下載
    • 商品評論0
    • 相關產品

    中文名稱:兔抗LRRC15多克隆抗體

    英文名稱: Anti-LRRC15 rabbit polyclonal antibody

    別    名: LIB

    相關類別: 一抗

    儲    存: 冷凍(-20℃)

    宿    主: Rabbit

    抗    原: LRRC15

    反應種屬: Human, Mouse, Rat

    標 記 物: Unconjugate

    克隆類型: rabbit polyclonal

    技術規(guī)格

    Background:

    Leucine-rich repeats (LRRs) are 20-29 amino acid motifs that mediate protein-protein interactions. The primary function of these motifs is to provide a versatile structural framework for the formation of these protein-protein interactions. LRRs are present in a variety of proteins with diverse structure and function, including innate immunity and nervous system development. Several human diseases are associated with mutations in genes encoding LRR-containing proteins. The leucine-rich repeat-containing protein 15 (LRRC15, also designated LIB) is a 581 amino acid protein that contains 15 LRR repeats and is involved in cell-cell and/or -extracellular matrix interactions. LRRC15 is frequently overexpressed in multiple tumor types, most notably breast carcinoma. It is also associated with the pathogenesis of Alzheimer’s disease.

    Applications:

    ELISA, IHC

    Name of antibody:

    LRRC15

    Immunogen:

    Fusion protein of human LRRC15

    Full name:

    leucine rich repeat containing 15

    Synonyms:

    LIB

    SwissProt:

    Q8TF66

    ELISA Recommended dilution:

    2000-10000

    IHC positive control:

    Human prostate cancer and Human cervical cancer

    IHC Recommend dilution:

    100-300





    產品掃碼查看詳情
    手機掃描查看
    <ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>